Parabilis Medicines, Inc. · NASDAQ:PBLS
Soleus Capital Group, LLC bought 500,000 Parabilis Medicines, Inc. shares (Form 4)
Traded Jun 11, 2026 · Filed Jun 29, 2026
On Jun 11, 2026, Soleus Capital Group, LLC (10% owner) bought 500,000 Parabilis Medicines, Inc. shares at US$20.00 for US$10M, leaving 527,070 shares. Filed Jun 29, 2026 (Form 4).
- Bought
- 500,000 shares
- Price
- US$20.00
- Value
- US$10M
- Holding after
- 527,070 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | Common Stock, par value $0.0001 per share | Buy | 375,000 | US$20.00 | 1,027,000 | Indirect |
| Jun 11, 2026 | Common Stock, par value $0.0001 per share | Buy | 125,000 | US$20.00 | 652,000 | Indirect |
| Jun 11, 2026 | Common Stock, par value $0.0001 per share | Conversion | 527,070 | US$9.48 | 527,070 | Indirect |
Source
Related
- Parabilis Medicines, Inc.
- Soleus Capital Group, LLC
- Parabilis Medicines, Inc. shareholders
- Schedule 13G · ARCH Venture Fund XII, L.P. · Aug 14, 2026
- Schedule 13G · FMR LLC · Aug 6, 2026
- Form 4 · Ra Capital Management, L.P. · Jul 22, 2026
- Schedule 13D · Ra Capital Management, L.P. · Jun 18, 2026
- Form 4 · Sebulsky Alan · Jun 16, 2026